rxstat › Classes › Drugs Used In Benign Prostatic Hypertrophy

Drugs Used In Benign Prostatic Hypertrophy: shortage status in Canada

4 of the 8 drugs used in benign prostatic hypertrophy rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Partial shortageAlfuzosin1 of 6 reported products affected · est. return Jun 26, 2026Partial shortageDutasteride1 of 12 reported products affected · est. return Aug 1, 2026Partial shortageFinasteride2 of 18 reported products affected · est. return Dec 31, 2026Partial shortageTamsulosin4 of 10 reported products affected · est. return Nov 13, 2026No current shortageSilodosinNo current shortageTamsulosin DutasterideDiscontinuedTerazosin0 of 1 reported products affectedNo current shortageTerazosin

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.